To evaluate whether imaging features of pathologic lymph nodes on whole-body diffusion-weighted MR have a predictive role before treatment and may assess the response after two courses of chemotherapy in comparison to FDG-PET/CT in Hodgkin Lymphoma.
Albano, D., Patti, C., Matranga, D., Lagalla, R., Midiri, M., Galia, M. (2018). Whole-body diffusion-weighted MR and FDG-PET/CT in Hodgkin Lymphoma: Predictive role before treatment and early assessment after two courses of ABVD. EUROPEAN JOURNAL OF RADIOLOGY, 103, 90-98 [10.1016/j.ejrad.2018.04.014].
Whole-body diffusion-weighted MR and FDG-PET/CT in Hodgkin Lymphoma: Predictive role before treatment and early assessment after two courses of ABVD
Albano, Domenico
;Matranga, Domenica;Lagalla, Roberto;Midiri, Massimo;Galia, Massimo
2018-01-01
Abstract
To evaluate whether imaging features of pathologic lymph nodes on whole-body diffusion-weighted MR have a predictive role before treatment and may assess the response after two courses of chemotherapy in comparison to FDG-PET/CT in Hodgkin Lymphoma.
File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
Albano, D.a_Wholebody-diffusionweighted-MR-and-FDGPETCT-in-Hodgkin-Lymphoma-Predictive-role-before-treatment-and-early-assessment-after-two-courses-of-ABVDArticle_2018.pdf
Solo gestori archvio
Dimensione
1.41 MB
Formato
Adobe PDF
|
1.41 MB | Adobe PDF | Visualizza/Apri Richiedi una copia |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
